Small Hospitals
Market Cap
₹32,233 ₹32,233 Cr.
P/E
157.77
PEG
5.40
PEG = P/E ÷ 5yr forward EPS CAGR
5yr forward EPS CAGR thesis · Base case

New hospital ramp-up defines the next three years: insurance empanelment is the single gating factor for revenue conversion, with bear case triggered by persistent delays that stall utilization.

Bull case requires GIPSA price revision, accelerated break-even at new units, and oversubscribed QIP enabling faster deleveraging, while mature units provide a stable base.

Execution risk concentrates in scaling FY26 new units and future expansions to deliver ₹4,400 Cr incremental revenue, as the business mix shifts from 85% mature to 59% mature.

Key Ratios

Debt to Equity
Debt to Equity
1.44
Div Yield (%)
Div Yield (%)
-
Individual < 2 lac
Individual < 2 lac
3.89 %
Institutions
Institutions
49.07 %
Market cap
Market cap
32,233 Cr
No. of Shareholders
No. of Shareholders
94,730
OPM (%)
OPM (%)
19.77 %
PE
PE
157
Prom Holding
Prom Holding
32.50 %
ROCE (%)
ROCE (%)
8.72
ROE (%)
ROE (%)
10.74
Sales
Sales
4,212 Cr
  • Krishna Inst.Medi
  • Narayana Hrudayalay.
  • Global Health
  • TJI Hospitals
Last updated on 15 Sep 2026
  • KIMS runs a multi-specialty hospital chain anchored by its Secunderabad flagship. Telangana is its largest cluster, with Andhra next and newer hospitals in Maharashtra, Karnataka and Kerala.
  • Patients pay mostly in cash at 53%, with insurance at 30%. Inpatient volumes rose 15% and outpatient volumes rose 25% in FY26.
  • KIMS was a Telangana and Andhra hospital chain. New hospitals commissioned in FY25-FY26 made it a five-state chain.
  • Profit comes from mature Telangana and Andhra hospitals at ~30% and ~25% margins. New Karnataka and Kerala clusters are still ramping and drag profit.
  • KIMS is stabilizing new hospitals and expanding via Kondapur, Rajahmundry and asset-light O&M deals. It plans no new geography beyond core markets.
  • QIP deleveraging has eased balance-sheet risk. Only ₹150cr of the ~₹600cr warrant issue is received, with ₹450cr contingent on conversion.
  • Earnings depend on narrowing new-hospital losses. Management guides Telangana EBITDA growth of 10-12% in FY27 and new-unit losses below half of FY26's ~₹128cr in FY27-28.
  • Execution remains the risk. Past capex timing and empanelment delays have slowed new-hospital ramps.
  • Remaining insurance empanelment end-Aug to mid-Sep 2026
    It settles whether the balance 50% approvals land and new-hospital volumes respond.
  • Arete O&M and call option Q2FY27; call no timeline
    KIMS gets 9% of net revenue. Call-option price and terms are undisclosed.
  • QIP interest saving early Nov 2026
    It shows the first full-quarter interest saving after deleveraging.
  • Bengaluru breakeven FY27; Electronic City by FY27-end
    The cluster reaches zero EBITDA in FY27. New-unit losses fall below half of FY26's ~₹128cr in FY27-28.
  • Kondapur ramp Phase 1 live Jun 2026; rest no date
    It adds ₹1,200cr annual revenue at ~30-32% margin over 4-5 years, about 30% of FY26 revenue. The pace is occupancy-led.
Price Range

See where the stock is trading versus its 52-week high and low.

Low
576
52W Range
High
858
Timeline

Key company specific updates.

Custom financial statement

Edit rows

Forensics

8 Yes

Positive for this company

2 Neutral

Neutral for this company

7 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Therapeutic Area Wise Break-Up - Domestic

Location Wise Break-Up

Customer Segment

Operating Profit Break-Up

Operational Metrics

    Select a Metric
    • Average Daily Revenue Per Occupied Bed (Rs)
    • Hospital Occupancy Rate (%)
    • Average Length Of Stay (Days)
    • Operational Beds (.)
    • Number of Outpatient Visits - Quarterly (.)
    • Inpatient Procedures (Thousand)
    • ARPU - In Patient (Rs)

    Peer Comparison

    Corporate Actions

    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less

    FAQs on Krishna Institute of Medical Sciences Ltd Business

    Krishna Institute of Medical Sciences Limited is a leading corporate healthcare group in AP and Telangana, providing multi-disciplinary healthcare services from primary to quaternary care in Tier 1-3 cities.

    Krishna Inst.Medi major competitors are Narayana Hrudayalay., Global Health, RainbowChildrenS Med, Healthcare Global, Yatharth Hospital, Jupiter Life Line, Kovai Medical Center.
    Market Cap of Krishna Inst.Medi is ₹32,326 Crs.
    While the median market cap of its peers are ₹10,095 Crs.

    Krishna Inst.Medi seems to be less financially stable compared to its competitors.
    Altman Z score of Krishna Inst.Medi is 4.7 and is ranked 6 out of its 8 competitors.

    Company Filing

    2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Feb May Aug May Aug Nov Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Sep Dec
    Investor Presentation Feb May Aug May Aug Nov Mar Jun Sep Dec Mar Jun Sep Dec Feb Mar May Jun Aug Sep Dec Sep Dec
    Conference Call Feb May Aug Mar Jun Nov Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec May Sep Dec
    Conference Call SummaryCon Call Summary

    Discussions & Analysis

    Krishna Institute of Medical Sciences Ltd
    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material